News Conference News AHA 2022 EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD Todd Neale November 06, 2022
News Conference News AHA 2022 Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions Yael L. Maxwell November 01, 2022
News Daily News AHA Urges More Home-Based Dialysis in Advanced Kidney Failure Michael O'Riordan August 18, 2022
News Daily News Many Hurdles to Clear Before Cardiac Xenotransplantation Takes Off Yael L. Maxwell June 16, 2022
Presentation TVT 2022 A CASE OF… Severe Functional Mitral Regurgitation in End-Stage HF: TEER as Bridge or Alternative to LVAD/Transplant Presenter: Ulrich Jorde June 09, 2022
News Opinion Off Script Amid Civil War and COVID-19, Cardiology in Sudan Takes Courage and Hope Nafisa Elsammani, MBBS, MD April 26, 2022
News Daily News Familial Patterns of Idiopathic Dilated Cardiomyopathy Becoming Clearer L.A. McKeown February 10, 2022
News Opinion Off Script Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation Charles C. Hong, MD, PhD February 04, 2022
Presentation THT 2022 The Care of the End-Stage Heart Failure Patient: Perspectives From the "Spoke" Presenter: Kumudha Ramasubbu February 02, 2022
News Features Realistic Expectations Emerge After Initial Excitement Over Xenotransplant Yael L. Maxwell January 21, 2022
News Opinion Fellow Talk A Trainee’s Perspective on the First Genetically Engineered Pig-to-Human Cardiac Xenotransplantation Corbin E. Goerlich, MD January 13, 2022
News Daily News With First-in-Human Porcine Heart Transplant, a New Chapter Begins Yael L. Maxwell January 11, 2022
News Daily News Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends Shelley Wood November 01, 2021
News Conference News TCT 2021 NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy L.A. McKeown October 22, 2021
News Conference News ESC 2021 Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD Michael O'Riordan August 28, 2021
News Daily News MitraClip Viable in Shock Patients With Significant MR: Observational Study Michael O'Riordan July 29, 2021